Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B‐Cell acute lymphoblastic leukemia
Abstract
Allogeneic hematopoietic cell transplantation (HCT) using human leukocyte antigen (HLA)–matched related donors (RDs) and allogeneic HCT using HLA‐matched unrelated donors (URDs) produce similar outcomes for patients with acute myelogenous leukemia, whereas the donor source has been reported to be a predictor of outcomes in myelodysplastic syndrome.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Apr 27, 2017
- Source ID
- 10.1002/cncr.30737
Entities
People
- Brenda M. Sandmaier
- Daniel J Weisdorf
- Eric Segal
- Hailin Wang
- Hanna J Khoury
- Marcos de Lima
- Michael J Martens
- Ruta Brazauskas
- Wael Saber
Organizations
- Emory University
- Health Resources and Services Administration
- Medical College of Wisconsin
- National Heart, Lung, and Blood Institute
- Office of Naval Research
- UH Cleveland Medical Center
- University of Minnesota
- University of Washington